Yahoo
NasdaqCM - Delayed Quote USD

SAB Biotherapeutics, Inc. (SABS)

3.7200 0.0000 (0.00%)
At close: September 4 at 4:00:00 PM EDT
3.7200 0.0000 (0.00%)
After hours: September 4 at 7:30:03 PM EDT
Trade SABS on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
0
Operating Expense
71,824.3630
48,953.3630
42,910.5200
38,075.3200
28,917.6170
Operating Income
-71,824.3630
-48,953.3630
-42,910.5200
-38,075.3200
-28,917.6170
Net Non Operating Interest Income Expense
3,880.3680
1,191.3680
967.5970
269.6820
-230.5120
Other Income Expense
55,168.6780
61,035.6780
7,837.6140
-4,388.1480
10,432.9540
Pretax Income
-12,775.3170
13,273.6830
-34,105.3090
-42,193.7860
-18,715.1750
Tax Provision
--
--
--
0
25.6290
Net Income Common Stockholders
-12,775.3170
13,273.6830
-34,105.3090
-42,193.7860
-18,740.8040
Average Dilution Earnings
--
-62,000.0730
0
--
--
Diluted NI Available to Com Stockholders
-74,775.3900
-48,726.3900
-34,105.3090
-42,193.7860
-18,740.8040
Basic EPS
1.25
0.22
-3.68
-7.64
-4.31
Diluted EPS
0.24
-0.79
-3.68
-7.64
-4.31
Basic Average Shares
48,049.4440
19,311.7980
9,261.9180
5,521.4870
4,352.4970
Diluted Average Shares
90,077.8380
61,340.1930
9,261.9180
5,521.4870
4,352.4970
Total Operating Income as Reported
-71,824.3630
-48,953.3630
-42,910.5200
-38,075.3200
-28,917.6170
Total Expenses
71,824.3630
48,953.3630
42,910.5200
38,075.3200
28,917.6170
Net Income from Continuing & Discontinued Operation
-12,775.3170
13,273.6830
-34,105.3090
-42,193.7860
-18,740.8040
Normalized Income
-69,527.5030
-49,480.5030
-39,490.3180
-37,370.5490
-26,956.1720
Interest Income
4,112.0320
1,432.0320
1,285.9980
584.9660
71.0720
Interest Expense
231.6640
240.6640
318.4010
315.2840
301.5840
Net Interest Income
3,880.3680
1,191.3680
967.5970
269.6820
-230.5120
EBIT
-12,543.6530
13,514.3470
-33,786.9080
-41,878.5020
-18,413.5910
EBITDA
-9,427.0670
16,595.9330
-28,994.3130
-38,133.2200
-15,121.7130
Reconciled Depreciation
3,116.5860
3,081.5860
4,792.5950
3,745.2820
3,291.8780
Net Income from Continuing Operation Net Minority Interest
-12,775.3170
13,273.6830
-34,105.3090
-42,193.7860
-18,740.8040
Total Unusual Items Excluding Goodwill
56,752.1860
62,754.1860
5,385.0090
-4,823.2370
10,399.2000
Total Unusual Items
56,752.1860
62,754.1860
5,385.0090
-4,823.2370
10,399.2000
Normalized EBITDA
-66,179.2530
-46,158.2530
-34,379.3220
-33,309.9830
-25,520.9130
Tax Rate for Calcs
0
0
0
0
0.0002
Tax Effect of Unusual Items
0
0
0
0
2,183.8320
12/31/2022 - 2/9/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: